LPIC
PFE icon

LeJeune Puetz Investment Counsel’s Pfizer PFE Stock Holding History

LeJeune Puetz Investment Counsel’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$3.08M Buy
75,451
+1,179
+2% +$50.9K 1.1% 24
2022
Q4 		$3.81M Buy
74,272
+200
+0.3% +$9.59K 1.42% 18
2022
Q3 		$3.24M Buy
74,072
+750
+1% +$36.4K 1.33% 18
2022
Q2 		$3.84M Sell
73,322
-1,000
-1% -$51K 1.5% 15
2022
Q1 		$3.85M Sell
74,322
-50
-0.1% -$2.59K 1.34% 18
2021
Q4 		$4.39M Buy
74,372
+1,000
+1% +$49.5K 1.48% 15
2021
Q3 		$3.16M Buy
73,372
+1,766
+2% +$78.2K 1.15% 22
2021
Q2 		$2.8M Buy
71,606
+2,175
+3% +$84.6K 1.04% 31
2021
Q1 		$2.52M Buy
69,431
+17,019
+32% +$604K 0.99% 35
2020
Q4 		$1.93M Sell
52,412
-2,461
-4% -$90.3K 0.83% 40
2020
Q3 		$1.91M Buy
54,873
+975
+2% +$34.2K 0.94% 34
2020
Q2 		$1.67M Hold
53,898
– – 0.87% 39
2020
Q1 		$1.67M Sell
53,898
-1,639
-3% -$55.8K 0.98% 35
2019
Q4 		$2.06M Sell
55,537
-817
-1% -$29.1K 0.97% 37
2019
Q3 		$1.92M Buy
56,354
+158
+0.3% +$5.75K 0.98% 36
2019
Q2 		$2.31M Sell
56,196
-316
-0.6% -$12.5K 1.19% 24
2019
Q1 		$2.28M Buy
56,512
+52
+0.1% +$2.08K 1.24% 23
2018
Q4 		$2.34M Buy
56,460
+3,089
+6% +$128K 1.46% 19
2018
Q3 		$2.23M Sell
53,371
-422
-0.8% -$16.2K 1.29% 23
2018
Q2 		$1.85M Sell
53,793
-3,952
-7% -$135K 1.14% 29
2018
Q1 		$1.94M Sell
57,745
-754
-1% -$25.9K 1.19% 27
2017
Q4 		$2.01M Sell
58,499
-1,344
-2% -$45.8K 1.23% 27
2017
Q3 		$2.03M Sell
59,843
-1,265
-2% -$40.7K 1.3% 25
2017
Q2 		$1.95M Sell
61,108
-1,412
-2% -$44.5K 1.32% 23
2017
Q1 		$2.03M Sell
62,520
-158
-0.3% -$4.98K 1.46% 20
2016
Q4 		$1.93M Buy
+62,678
New +$1.91M 1.48% 17

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LeJeune Puetz Investment Counsel's PFE Position: Q1 2023 in Review

LeJeune Puetz Investment Counsel increased its Pfizer (PFE) stake by 1.6% in Q1 2023, buying an estimated $50.9K and bringing the position to 75,451 shares worth $3.08M. The position accounts for 1.1% of the portfolio, ranked #24.

LeJeune Puetz Investment Counsel first reported a position in PFE in Q4 2016 and has held it in 26 quarters since. The position peaked at $4.39M in Q4 2021. 3,103 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

  • LeJeune Puetz Investment Counsel held 75,451 shares of Pfizer worth $3.08M as of Q1 2023.
  • LeJeune Puetz Investment Counsel bought 1,179 Pfizer shares in Q1 2023, an estimated $50.9K.
  • Pfizer made up 1.1% of LeJeune Puetz Investment Counsel's portfolio in Q1 2023, its #24 holding.
  • LeJeune Puetz Investment Counsel first reported a position in Pfizer in Q4 2016 and has held it in 26 quarters since.
  • LeJeune Puetz Investment Counsel's Pfizer position peaked at $4.39M in Q4 2021.
  • 3,103 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on LeJeune Puetz Investment Counsel's 13F filing for Q1 2023, filed 3 May 2023.